Hyderabad: Hyderabad-based MSN Laboratories (MSN Labs) launched Empagliflozin tablets (SGLT2i), a drug used for diabetes management, under the brand name ‘Empaone’. The medicine will cost Rs 15.90 and Rs 18.90 for each 10 mg and 25 mg tablet, respectively. India being the diabetic capital of the world with over 77 million people suffering from Type […]
Hyderabad: Hyderabad-based MSN Laboratories became the first company to launch the generic Canreal injection (Cangrelor) in India, indicated as an adjunct to percutaneous coronary intervention (PCI), also known as coronary angioplasty, a nonsurgical procedure that improves blood flow to heart. The drug reduces the risk of periprocedural myocardial infarction (MI), repeat coronary revascularisation, and stent […]
The company said its new division will focus on presenting a comprehensive range of affordable, high quality, bioequivalent generic oncology medicines benefiting patients in India.
Developed by the DRDO, 2-DG has been granted permission by Drug Controller General of India for emergency use as adjunct therapy in moderate to severe Covid-19 patients.
The drug baricitinib has been granted a restricted emergency use approval in India by the Central Drugs Standard Control Organization (CDSCO) for emergency use in combination with remdesivir for the treatment of suspected or laboratory confirmed Covid-19
